Gestalt Diagnostics raised $7.5 million in Series A funding led by Cowles Ventures and others to expand its AI-powered pathology platform.
Amount Raised
$7.5 Million
Round Type
Series A
SpokaneBiotechnologyHealthcareHealth CareArtificial IntelligenceInvestors
Description
Gestalt, a leader in AI-powered digital pathology, announced a $7.5 million Series A financing led by Cowles Ventures. The funding will facilitate market adoption and enhance AI capabilities for its PathFlow platform, which improves diagnostics. With rising cancer rates, the capital will also pursue FDA clearance and expand the customer base. Investors expressed continued support for the company's vision to transform pathology through digital workflows.
Quick answer
Gestalt Diagnostics raised $7.5 Million in a Series A round, dated April 28, 2025. Investors: KickStart Funds, Inland Imaging Investments, Tvf Funds and Cowles Ventures. Gestalt Diagnostics is based in Spokane, Washington, United States.
- How much did Gestalt Diagnostics raise?
- Gestalt Diagnostics raised $7.5 Million in a Series A round on April 28, 2025.
- Who invested in Gestalt Diagnostics?
- KickStart Funds, Inland Imaging Investments, Tvf Funds and Cowles Ventures are named as investors in this round.
- What does Gestalt Diagnostics do?
- Gestalt transforms pathology through an intelligent, configurable, vendor-neutral, and AI-driven digital workflow that provides true interoperability enabling pathologists to diagnose* diseases faster and more..
- Where is Gestalt Diagnostics based and how big is it?
- Gestalt Diagnostics is based in Spokane, Washington, United States.
- Who are the decision-makers at Gestalt Diagnostics?
- Fundz holds 1 contact at Gestalt Diagnostics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Healthcare and Biotechnology around the same time
Companies in the same sectors as Gestalt Diagnostics that raised within 45 days of this round, from Fundz verified event records.
- Ryght raised $3M (Seed) on June 12, 2025.
- Iom Bioworks raised $468K (Seed) on June 12, 2025.
- Autonomize raised $28M (Series A) on June 12, 2025.
- Synaptogenix raised $5.5M on June 9, 2025.
- Cosm Medical raised an undisclosed amount (Seed) on June 5, 2025.
- TuHURA Biosciences raised $13M (Private Equity) on June 3, 2025.
Who to call at Gestalt Diagnostics, and when
A new round usually means Gestalt Diagnostics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Gestalt Diagnostics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Gestalt Diagnostics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Gestalt Diagnostics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gestalt Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansGestalt Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.